Buy or sell OncoCyte stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

OncoCyte Stock

Focused on cancers with large patient populations and significant unmet need.

Headquarters

Alameda CA, US

About OncoCyte Stock

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.The company believes that better and earlier detection of cancer through liquid biopsies will: Improve patient outcomes Increase the life expectancy of cancer patients Significantly reduce health care costs Current diagnostic standards fall short by many measures. At present, diagnostic tests for cancer rely on scans and then tissue samples from invasive surgical procedures to determine if a tumor is benign or malignant.

Management

President & CEO

William Annett

CFO

RUSSELL SKIBSTED

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from OncoCyte or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo